Literature DB >> 1350633

Torasemide, but not frusemide, increases intracellular cAMP and cGMP content in the aorta of the renal hypertensive rat.

K Yamanaga1, T Uchida, H Kido, K Hayashi, M Watanabe.   

Abstract

Repeated oral administration of the novel loop diuretic torasemide (3 mg kg-1) and frusemide (30 mg kg-1) for 7 days, elicited a significant fall in the systolic blood pressure in the one-kidney, one-clip Goldblatt renal hypertensive rat (RHR). The hypotensive action was greater in the torasemide group than in the frusemide group. Furthermore torasemide increased intracellular cAMP and cGMP content in aorta of RHR. Frusemide caused no effect. It is hypothesized that the increase in adenosine- or guanosine-nucleotides is involved in the antihypertensive action of torasemide, but not in that of frusemide.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350633     DOI: 10.1111/j.2042-7158.1992.tb14367.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

1.  Proteomic differences among patients with heart failure taking furosemide or torsemide.

Authors:  Lauren B Cooper; Scott Bruce; Mitchell Psotka; Robert Mentz; Rachel Bell; Stephen L Seliger; Christopher O'Connor; Christopher deFilippi
Journal:  Clin Cardiol       Date:  2022-01-11       Impact factor: 3.287

2.  Effect of aliskiren, telmisartan and torsemide on cardiac dysfunction in l-nitro arginine methyl ester (l-NAME) induced hypertension in rats.

Authors:  Sawsan A Sadek; Laila A Rashed; Amira M Bassam; Eman S Said
Journal:  J Adv Res       Date:  2014-11-20       Impact factor: 10.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.